Brief: Marksans Pharma Raises 3.72 Billion Rupees Via Conversion Of Warrants Into Shares By Orbimed Asia Iv Mauritius Fvci, Promoter Mark Saldanha
20/01/2023 05:04
Jan 20 (Reuters) - Marksans Pharma Ltd MARK.NS :
* RAISED 3.72 BILLION RUPEES VIA CONVERSION OF WARRANTS INTO
SHARES BY ORBIMED ASIA IV MAURITIUS FVCI, PROMOTER MARK SALDANHA
Source text for Eikon: ID:nBSE5j5HMm
Further company coverage: MARK.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg